InsidersTradesSigma
Follow the Lasa Supergenerics Limited share price and the full management transaction log of the company, a listed issuer based in India. Shares are quoted on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Lasa Supergenerics Limited has published 6 public disclosures. Market capitalisation: €344.2m. The latest transaction was reported on 1 April 2023 (Sale). Among the most active insiders: Omkar Herlekar. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
Lasa Supergenerics Limited is a company engaged in the manufacturing of generic pharmaceutical products. It primarily operates in the Indian market and focuses on both human and animal health segments.